Massive Pulmonary Embolism on Low-Dose Combined Oral Contraceptive in a 40-Year-Old Asian Woman with BMI 32

Key finding

> Three modifiable risk factors were present simultaneously and each had already been individually accepted as within-guideline: a BMI classified as "Class I," hypertension classified as "controlled," and a contraceptive classified as "low-dose." None of the three triggered escalation. Their product nearly killed her. > > Menstrual irregularity in a 40-year-old woman with central obesity and hypertension is itself a metabolic signal — most plausibly PCOS-spectrum or insulin-resistance-driven anovulation. It was treated as a gynaecological complaint to be normalised with oestrogen, rather than as the presenting symptom of a metabolic syndrome that already contraindicated oestrogen. ---

Framework connections: The Overflow Tank, The Sick Fat Cell, The Missing Mechanics (EPCs), The Signal Fire (IL-6)

← All highlights · The full case file, with extracted biomarkers and clinical questions, opens with registered access.